Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)
Ufp Technologies (UFPT) posted Liabilities and Shareholders Equity of $674.7 million for Q1 2026, up 2.99% on a QoQ basis from $655.1 million in Q4 2025, and up 4.99% year-over-year from $642.6 million in Q1 2025.
Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Ufp Technologies' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $674.7 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 4.99% year-over-year to $674.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 12.21% YoY) and the FY2025 annual result came in at $655.1 million, up 4.15% from the prior year.
- Liabilities and Shareholders Equity was $674.7 million for Q1 2026 at Ufp Technologies, up from $655.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $674.7 million in Q1 2026 and bottomed at $363.3 million in Q1 2022.
- A 5-year average of $498.5 million and a median of $407.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 81.81% — and 2023, when it climbed 0.74%.
- Ufp Technologies' Liabilities and Shareholders Equity stood at $378.2 million in 2022, then climbed by 6.86% to $404.1 million in 2023, then jumped by 55.64% to $629.0 million in 2024, then climbed by 4.15% to $655.1 million in 2025, then increased by 2.99% to $674.7 million in 2026.
- Business Quant data shows UFPT's Liabilities and Shareholders Equity at $674.7 million in Q1 2026, $655.1 million in Q4 2025, and $652.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 674.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 674.68 Mn |
| Dec 31, 2025 | 655.08 Mn |
| Sep 30, 2025 | 652.82 Mn |
| Jun 30, 2025 | 634.66 Mn |
| Mar 31, 2025 | 642.64 Mn |
| Dec 31, 2024 | 629.00 Mn |
| Sep 30, 2024 | 638.51 Mn |
| Jun 30, 2024 | 422.40 Mn |
| Mar 31, 2024 | 407.68 Mn |
| Dec 31, 2023 | 404.14 Mn |
| Sep 30, 2023 | 399.81 Mn |
| Jun 30, 2023 | 397.99 Mn |
| Mar 31, 2023 | 390.78 Mn |
| Dec 31, 2022 | 378.19 Mn |
| Sep 30, 2022 | 388.32 Mn |
| Jun 30, 2022 | 395.05 Mn |
| Mar 31, 2022 | 363.35 Mn |
| Dec 31, 2021 | 334.13 Mn |
| Sep 30, 2021 | 220.69 Mn |
| Jun 30, 2021 | 217.29 Mn |